Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» October 2010
October 2010
Drugmakers rack up $1B in small deals
Drugmakers rack up $1B in small deals
Fierce Pharma
M&A
Sanofi
BMP Sunstone
Teva Pharmaceuticals
Theramex
Merck KGaA
Hikma
Baxter International
U.S. Panel Debates Value of HPV Vaccine for Boys
U.S. Panel Debates Value of HPV Vaccine for Boys
NY Times, NY
HPV
vaccines
Gardasil
Cervarix
GSK
Merck
Vivus Gains on Potential to Win U.S. Clearance for Obesity Drug Next Year
Vivus Gains on Potential to Win U.S. Clearance for Obesity Drug Next Year
Bloomberg
Qnexa
FDA
obesity
Vivus
Geron Q3 loss grows to $18.3M
Geron Q3 loss grows to $18.3M
Bizjournals.com
earnings
Geron
Whither Diet Pills? Why The FDA Keeps Saying No
Whither Diet Pills? Why The FDA Keeps Saying No
Pharmalot
Vivus
Qnexa
obesity
diet pills
Arena Pharmaceuticals
FDA
GlaxoSmithKline licenses Amicus drug in $230M deal
GlaxoSmithKline licenses Amicus drug in $230M deal
Bizjournals.com
Amicus Therapeutics
GSK
licensing
Amigal
Fabry's disease
Forest Labs says COPD drug meets study goal
Forest Labs says COPD drug meets study goal
Yahoo/AP
COPD
Forest Labs
aclidinium bromide
J&J Has Nothing to Add to Public Statement Oct. 6 on Crucell
J&J Has Nothing to Add to Public Statement Oct. 6 on Crucell
Bloomberg
JNJ
Crucell
vaccines
Merck Net Falls 90%, Hikes EPS Target
Merck Net Falls 90%, Hikes EPS Target
TheStreet.com
Merck
earnings
Vivus Fails to Win U.S. Approval for Diet Pill Qnexa on Safety Concerns
Vivus Fails to Win U.S. Approval for Diet Pill Qnexa on Safety Concerns
Bloomberg
FDA
diet drugs
Qnexa
Vivus
obesity
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »